Arkadios Wealth Advisors’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,480
| Closed | -$440K | – | 885 |
|
|
2024
Q1 | $440K | Hold |
32,480
| – | – | 0.03% | 408 |
|
|
2023
Q4 | $351K | Buy |
32,480
+4,500
| +16% | +$48.6K | 0.03% | 466 |
|
|
2023
Q3 | $182K | Hold |
27,980
| – | – | 0.02% | 624 |
|
|
2023
Q2 | $504K | Hold |
27,980
| – | – | 0.06% | 305 |
|
|
2023
Q1 | $658K | Hold |
27,980
| – | – | 0.08% | 249 |
|
|
2022
Q4 | $700K | Hold |
27,980
| – | – | 0.09% | 228 |
|
|
2022
Q3 | $890K | Hold |
27,980
| – | – | 0.13% | 170 |
|
|
2022
Q2 | $1.11M | Hold |
27,980
| – | – | 0.16% | 160 |
|
|
2022
Q1 | $1.13M | Hold |
27,980
| – | – | 0.15% | 168 |
|
|
2021
Q4 | $1.41M | Hold |
27,980
| – | – | 0.19% | 127 |
|
|
2021
Q3 | $1.82M | Buy |
27,980
+20,980
| +300% | +$1.36M | 0.26% | 96 |
|
|
2021
Q2 | $271K | Buy |
+7,000
| New | +$271K | 0.03% | 467 |
|